BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

May 10, 2021

View Archived Issues

Keymed evaluates CM-310 in phase II for chronic rhinosinusitis with nasal polyposis

Read More

PEP-010 enters first-in-human study in solid tumors

Read More

iBio advances COVID-19 vaccine programs

Read More

Russia authorizes use of single-dose Sputnik Light COVID-19 vaccine

Read More

Sangamo Therapeutics patents chimeric antigen receptors targeting IL-23

Read More

Lead Pharma Holding presents new ERR-alpha inverse agonists

Read More

New TRPA1 antagonists identified at Boehringer Ingelheim

Read More

PTPN11 inhibitors discovered at Hangzhou Rex Pharmaceutical

Read More

Bayer, Deutsches Krebsforschungszentrum present new MAP4K1 inhibitors

Read More

UCB identifies antiepileptic compounds improving on padsevonil

Read More

Study of a new CAIX-targeting radiotracer, [99mTc]PHC-102, for SPECT imaging in ccRCC patients

Read More

SparingVision studies ocular gene therapy SPVN-06 in primates

Read More

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

Read More

Reduced galectin-3 observed in central serous chorioretinopathy

Read More

Allysta Pharmaceutical initiates first-in-human study of ALY-688-SR

Read More

Enrollment ongoing in phase II study of JNJ-40411813 as adjunctive therapy in epilepsy

Read More

NuBiyota starts phase II study of MET-2 in subjects with major depression

Read More

Enrollment begins in phase II study of NeoVax cancer vaccine in patients with CLL

Read More

Telix cleared in Australia to begin phase III study of TLX-591 for metastatic CRPC

Read More

KNP-301 tested in mouse models of AMD

Read More

VIP-236 demonstrates potent antitumor efficacy in xenograft models

Read More

China NMPA approves bevacizumab biosimiilar LY-01008

Read More

Preclinical data presented for the ocular anesthetic AG-920

Read More

Cantargia plans to study CAN-04 with carboplatin/gemcitabine in advanced TNBC

Read More

Phase III FIGARO-DKD cardiovascular outcomes study of finerenone meets primary endpoint

Read More

Findings bolster RAD51 as biomarker for DNA repair deficiency

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 4, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 4, 2025.
  • Green molecules

    UK Biobank delivers largest metabolomics dataset of 500K profiles

    BioWorld Science
    It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
  • 3D rendering of prion structure

    Epigenetic technology could eliminate misfolded prion proteins

    BioWorld Science
    The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
  • Mesothelin is biomarker, potential target in arthritic bone damage

    BioWorld Science
    In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing